Biomédica: revista del Instituto Nacional de Salud (May 2024)

Diabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA)

  • Luis Eduardo Echeverría,
  • Clara Saldarriaga,
  • Sebastián Campbell-Quintero,
  • Lisbeth Natalia Morales-Rodríguez,
  • Juan David López-Ponce de León,
  • Andrés Felipe Buitrago,
  • Erika Martínez-Carreño,
  • Jorge Alberto Sandoval-Luna,
  • Alexis Llamas,
  • Gustavo Adolfo Moreno-Silgado,
  • Julián Vanegas-Eljach,
  • Nelson Eduardo Murillo-Benítez,
  • Ricardo Gómez-Paláu,
  • Alex Arnulfo Rivera-Toquica,
  • Juan Esteban Gómez-Mesa,
  • RECOLFACA research group

DOI
https://doi.org/10.7705/biomedica.6951
Journal volume & issue
Vol. 44, no. Sp. 1
pp. 182 – 197

Abstract

Read online

Introduction. Heart failure and type 2 diabetes mellitus are critical public health issues. Objective. To characterize the risk factors for mortality in patients with heart failure and type 2 diabetes mellitus from a large registry in Colombia and to evaluate the potential effect modifications by type 2 diabetes mellitus over other risk factors. Materials and methods. Heart failure patients with and without type 2 diabetes mellitus enrolled in the Registro Colombiano de Falla Cardíaca (RECOLFACA) were included. RECOLFACA enrolled adult patients with heart failure diagnosis from 60 medical centers in Colombia during 2017-2019. The primary outcome was all-cause mortality. Survival analysis was performed using adjusted Cox proportional hazard models. Results. A total of 2514 patients were included, and the prevalence of type 2 diabetes mellitus was 24.7% (n = 620). We found seven independent predictors of short-term mortality for the general cohort, chronic obstructive pulmonary disease, sinus rhythm, triple therapy, nitrates use, statins use, anemia, and hyperkalemia. In the type 2 diabetes mellitus group, only the left ventricle diastolic diameter was an independent mortality predictor (HR = 0.96; 95% CI: 0.93-0.98). There was no evidence of effect modification by type 2 diabetes mellitus on the relationship between any independent predictors and all-cause mortality. However, a significant effect modification by type 2 diabetes mellitus between smoking and mortality was observed. Conclusions. Patients with type 2 diabetes mellitus had higher mortality risk. Our results also suggest that type 2 diabetes mellitus diagnosis does not modify the effect of the independent risk factors for mortality in heart failure evaluated. However, type 2 diabetes mellitus significantly modify the risk relation between mortality and smoking in patients with heart failure.

Keywords